The Action of Bismuth against Helicobacter pylori Mimics but Is Not Caused by Intracellular Iron Deprivation

ABSTRACT Helicobacter pylori is highly susceptible to bismuth, a heavy metal with antimicrobial activity linked to its effect on bacterial iron uptake. Three strains of H. pylori were analyzed for indicators of iron limitation following exposure to the MIC of colloidal bismuth subcitrate (MICCBS). Similar morphologic and outer membrane changes were observed following growth in iron-limiting medium and at the MICCBS that inhibited the growth of all three strains. These changes, which were also observed for iron-limited bacteria, were alleviated by the addition of iron to the cultures. H. pylori ATP levels, reduced in iron-limiting medium, were below the limits of detection in two of the three strains following exposure to bismuth. The addition of iron partially restored bacterial ATP levels in these two strains, although not to normal concentrations. In contrast, exposure of the same strains to the MICCBS failed to deplete intracellular levels of iron, which were significantly reduced by culturing in iron-limiting medium. Thus, the antimicrobial effect of bismuth and of iron limitation on H. pylori may be similar. However, the respective mechanisms of intracellular action would appear to be mediated by different pathways within the cell.

[1]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[2]  J. Wong,et al.  Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. , 1982, Gastroenterology.

[3]  M. Vaara,et al.  Polycations sensitize enteric bacteria to antibiotics , 1983, Antimicrobial Agents and Chemotherapy.

[4]  C. Mcnulty,et al.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents , 1985, Antimicrobial Agents and Chemotherapy.

[5]  M. Hardman,et al.  COMPARISON OF TRI-POTASSIUM DI-CITRATO BISMUTHATE TABLETS WITH RANITIDINE IN HEALING AND RELAPSE OF DUODENAL ULCERS , 1985, The Lancet.

[6]  C. Goodwin,et al.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. , 1986, The Journal of antimicrobial chemotherapy.

[7]  T. Emery Exchange of iron by gallium in siderophores. , 1986, Biochemistry.

[8]  D. V. van Caekenberghe,et al.  In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori) , 1987, Antimicrobial Agents and Chemotherapy.

[9]  J. Armstrong,et al.  Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study. , 1987, Journal of medical microbiology.

[10]  C. O'Morain,et al.  CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY , 1987, The Lancet.

[11]  B. Marshall,et al.  Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. , 1987, Digestion.

[12]  B. Marshall,et al.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. , 1988, Journal of clinical pathology.

[13]  H. Zanen,et al.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. , 1988, Gastroenterology.

[14]  Guido N. J. Tytgat,et al.  Campylobacter pyloridis-associated chronic active antral gastritis. , 1988 .

[15]  D. Morgan,et al.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. , 1988, Journal of medical microbiology.

[16]  T. Sox,et al.  Binding and killing of bacteria by bismuth subsalicylate , 1989, Antimicrobial Agents and Chemotherapy.

[17]  M. Blaser,et al.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity , 1990, Infection and immunity.

[18]  P. Domenico,et al.  Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate. , 1991, The Journal of antimicrobial chemotherapy.

[19]  V. Appanna,et al.  Gallium toxicity and adaptation in Pseudomonas fluorescens. , 1992, FEMS microbiology letters.

[20]  Helicobacter pylori: its role in disease. , 1992 .

[21]  P. Malfertheiner,et al.  The coccoid forms of Helicobacter pylori. Criteria for their viability , 1993, Epidemiology and Infection.

[22]  W. Baer,et al.  Effects of substances inhibiting or uncoupling respiratory-chain phosphorylation of Helicobacter pylori. , 1993, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[23]  J. de Graaff,et al.  Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake , 1995, Infection and immunity.

[24]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[25]  K. Sewing,et al.  Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase. , 1995, Pharmacology.

[26]  P. Domenico,et al.  Resistance to bismuth among gram-negative bacteria is dependent upon iron and its uptake. , 1996, The Journal of antimicrobial chemotherapy.

[27]  C. Conaghan,et al.  Comparison of histological and biochemical hepatic iron indexes in the diagnosis of genetic haemochromatosis. , 1996, Journal of clinical pathology.

[28]  M. Borodovsky,et al.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Blaser,et al.  Analysis of F1F0-ATPase from Helicobacter pylori , 1997, Infection and immunity.

[30]  M. Husson,et al.  Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori , 1997, Infection and immunity.

[31]  J. Keenan,et al.  Dual silver staining to characterise Helicobacter spp. outer membrane components. , 1997, Journal of immunological methods.

[32]  M F Dixon,et al.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.

[33]  A. Moran Coccoid forms of Helicobacter pylori. , 1997, Helicobacter.

[34]  P. Midolo,et al.  The actions of bismuth in the treatment of Helicobacter pylori infection , 1997, Alimentary pharmacology & therapeutics.

[35]  S. Bereswill,et al.  Cloning and characterization of the fur gene from Helicobacter pylori. , 1998, FEMS microbiology letters.

[36]  P. Stewart,et al.  Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment. , 1999, The Journal of antimicrobial chemotherapy.

[37]  P. Midolo,et al.  In Vitro Synergy Between Ranitidine Bismuth Citrate and Tetracycline or Clarithromycin Against Resistant Strains of Helicobacter pylori , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[38]  Burke A. Cunha,et al.  Surface Antigen Exposure by Bismuth Dimercaprol Suppression of Klebsiella pneumoniae Capsular Polysaccharide , 1999, Infection and Immunity.

[39]  T. Alarcón,et al.  Antibiotic resistance problems with Helicobacter pylori. , 1999, International journal of antimicrobial agents.

[40]  Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection. , 1999 .

[41]  C. Stratton,et al.  Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts. , 1999, The Journal of antimicrobial chemotherapy.

[42]  C. Ratledge,et al.  Iron metabolism in pathogenic bacteria. , 2000, Annual review of microbiology.

[43]  L. Andersen,et al.  Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate. , 2000, International journal of antimicrobial agents.

[44]  G. Tytgat,et al.  Regular review: treatment of Helicobacter pylori infection. , 2000, BMJ.

[45]  J. Keenan,et al.  Iron influences the expression of Helicobacter pylori outer membrane vesicle‐associated virulence factors , 2000, European journal of gastroenterology & hepatology.

[46]  S. Bereswill,et al.  Regulation of Ferritin-Mediated Cytoplasmic Iron Storage by the Ferric Uptake Regulator Homolog (Fur) of Helicobacter pylori , 2000, Journal of bacteriology.

[47]  Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. , 2000 .

[48]  R. Haas,et al.  Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. , 2000, Science.

[49]  S. Savvides,et al.  Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. , 2000, Molecular cell.

[50]  Burke A. Cunha,et al.  Activities of Bismuth Thiols against Staphylococci and Staphylococcal Biofilms , 2001, Antimicrobial Agents and Chemotherapy.

[51]  M. Stoltenberg,et al.  Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate. , 2001, Scandinavian journal of gastroenterology.

[52]  J. Crabtree,et al.  The Mouse Colonizing Helicobacter pylori Strain SS1 May Lack a Functional cag Pathogenicity Island , 2002, Helicobacter.

[53]  Edward J. Wood,et al.  Biochemistry (3rd ed.) , 2004 .

[54]  V. Lorian Antibiotics in laboratory medicine , 2005 .

[55]  L. Barton,et al.  Effects of iron(III) analogs on growth and pseudobactin synthesis in a chromiumtolerantPseudomonas isolate , 2005, Biology of Metals.